Cargando…

Delayed diagnosis of polycythaemia vera in an adult female with non-cirrhotic portal hypertension

Polycythaemia vera (PV) is a rare myeloproliferative neoplasm characterized primarily by erythrocytosis and an increased risk of thrombosis. We report a case of PV in a 60-year-old female with diabetes mellitus (DM) and a past history of recurrent abdominal pain and documented oesophageal varices wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tachi, Kenneth, Ekem, Victor, Dei-Adomakoh, Yvonne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ghana Medical Association 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334950/ https://www.ncbi.nlm.nih.gov/pubmed/35919777 http://dx.doi.org/10.4314/gmj.v56i1.6

Ejemplares similares

Koilonychia and Polycythæmia Vera
por: Glazebrook, A. J.
Publicado: (1944)

Unusual Neurological Symptoms in Polycythæmia Rubra Vera
por: Grunberg, A., et al.
Publicado: (1950)

Haemoglobinopathia Ypsilanti – A rare, but important differential diagnosis to polycythaemia vera()
por: Nygaard, Marietta, et al.
Publicado: (2013)

Masked polycythaemia vera is genetically intermediate between JAK2V617F mutated essential thrombocythaemia and overt polycythaemia vera
por: Tiong, I S, et al.
Publicado: (2016)

The treatment of polycythaemia vera: an update in the JAK2 era
por: Finazzi, G., et al.
Publicado: (2007)

Polycythæmia Vera with Tuberculosis Splenomegaly. Report of a Case
por: Guild, A. A., et al.
Publicado: (1950)

Splenic Infarctions in Polycythaemia Vera are Not Always a Catastrophe
por: Abdalla, ELMustafa, et al.
Publicado: (2022)

Improvement in polycythaemia vera after parathyroidectomy for primary hyperparathyroidism
por: Sthaneshwar, Pavai, et al.
Publicado: (2022)

The epidemiology of polycythaemia rubra vera in England and Wales 1968-1982.
por: Prochazka, A. V., et al.
Publicado: (1986)

Crescentic Glomerulonephritis Associated with Polycythaemia Vera: A Rare Occurrence
por: Dwivedi, Rohan, et al.
Publicado: (2022)

Recent Advances in the Use of Molecular Analyses to Inform the Diagnosis and Prognosis of Patients with Polycythaemia Vera
por: Stuckey, Ruth, et al.
Publicado: (2021)

Association of polycythemia vera with non‑cirrhotic portal hypertension in five patients: A case series
por: Zhang, Lili, et al.
Publicado: (2023)

MTAP-related increased erythroblast proliferation as a mechanism of polycythaemia vera
por: Tipgomut, Chartsiam, et al.
Publicado: (2021)

Skin cancer in essential thrombocythaemia and polycythaemia vera patients treated with hydroxycarbamide
por: Mathur, Abhinav, et al.
Publicado: (2022)

Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice
por: Amé, Shanti, et al.
Publicado: (2023)

Polycythaemia Vera among Sudanese Patients with Special Emphasis on JAK2 Mutations
por: Ibrahim, Ibrahim Khidir, et al.
Publicado: (2019)

Longitudinal trends of peripheral blood counts in polycythaemia vera and essential thrombocythemia patients in the UK
por: Carpenter, Lewis, et al.
Publicado: (2022)

Development and validation of a sequential two-step algorithm for the screening of individuals with potential polycythaemia vera
por: Piris-Villaespesa, Miguel, et al.
Publicado: (2021)

Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension
por: Biecker, Erwin
Publicado: (2013)

Causes and Management of Non-cirrhotic Portal Hypertension
por: Gioia, Stefania, et al.
Publicado: (2020)

Wall shear stress in portal vein of cirrhotic patients with portal hypertension
por: Wei, Wei, et al.
Publicado: (2017)

Steroid-induced dysglycaemia in patients with haematological disorders a ten-year review in a tertiary hospital in Ghana
por: Dei-Adomakoh, Yvonne A, et al.
Publicado: (2019)

The Impact of Partial Splenic Embolization on Portal Hypertensive Gastropathy in Cirrhotic Patients with Portal Hypertension
por: Saeki, Michio, et al.
Publicado: (2023)

Cognitive Impairement in Non-Cirrhotic Portal Hypertension: Highlights on Physiopathology, Diagnosis and Management
por: Gioia, Stefania, et al.
Publicado: (2021)

A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: A British Society for Haematology Guideline
por: McMullin, Mary F. F., et al.
Publicado: (2018)

Polycythaemia treated with nephrectomy
por: Thuesen, Anne Daugaard, et al.
Publicado: (2011)

Cardiac dysfunction in cirrhotic portal hypertension with or without ascites
por: Dadhich, Sunil, et al.
Publicado: (2014)

Idiopathic non-cirrhotic portal hypertension: a review
por: Schouten, Jeoffrey NL, et al.
Publicado: (2015)

The beneficial effects of curcumin in cirrhotic rats with portal hypertension
por: Hsu, Shao-Jung, et al.
Publicado: (2017)

Research progress on signaling pathways in cirrhotic portal hypertension
por: Xu, Wen, et al.
Publicado: (2018)

Cirrhotic portal hypertension: From pathophysiology to novel therapeutics
por: Gunarathne, Lakmie S, et al.
Publicado: (2020)

Non-cirrhotic portal hypertension in an ankylosing spondylitis patient
por: Park, Sukki, et al.
Publicado: (2018)

Non-Cirrhotic Portal Hypertension in Systemic Lupus Erythematosus
por: Suárez-Díaz, Silvia, et al.
Publicado: (2023)

Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension
por: Uschner, Frank E., et al.
Publicado: (2015)

P1001: DNMT3A/TET2/ASXL1 MUTATIONS DETERMINE THROMBOTIC RISK IN POLYCYTHAEMIA VERA
por: Segura Diaz, A., et al.
Publicado: (2022)

Splenic arteriovenous fistula leading to non-cirrhotic portal hypertension: a case report: Splenic arteriovenous fistula leading to non-cirrhotic portal hypertension
por: Abou Yassine, Ahmad, et al.
Publicado: (2023)

Nitro-oxidative stress, VEGF and MMP-9 in patients with cirrhotic and non-cirrhotic portal hypertension
por: MUTI, LEON ADRIAN, et al.
Publicado: (2015)

Pathological abnormalities in splenic vasculature in non-cirrhotic portal hypertension: Its relevance in the management of portal hypertension
por: Gupta, Shahana, et al.
Publicado: (2020)

Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension
por: Kreisel, Wolfgang, et al.
Publicado: (2020)

Chronic Myeloid Leukemia Presenting as Non-cirrhotic Portal Hypertension
por: Gemnani, Rinkle R, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_887sbaq7dv7nea7ljmnfshhrh9